StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –

Novartis Net Sales in the U.S. by Year

Net Sales in the U.S. ($M)

QuarterlyAnnual

Novartis Net Sales in the U.S.: $867M in FY2025, up 2.2% from a year earlier. That is the highest of the 8 years on record here.

Latest, FY2025
867
Period ended Dec 31, 2025
Change on a year earlier
+2.2%
848 in FY2024
History
8 years
Since FY2018
Sources
8
Documents cited below

Where the FY2025 figure comes from

“|| Tafinlar + Mekinist | Oncology | BRAF V600+ metastatic and adjuvant melanoma, advanced non-small cell lung cancer (NSCLC), tumor agnostic with BRAF mutation indication, pediatric low grade glioma (pLGG) | 867 | 2 | 1 348 | 11 | 9 | 2 215 | 8 | 6”

Source: Novartis Form 6-K (0001114448-26-000007) ↗

Reported in Form 6-K & Form 20-F (Top 20 Brands US / Rest of World).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet Sales in the U.S. ($M)Year on yearSource
FY2025Dec 31, 2025867+2.2%Novartis Form 6-K (0001114448-26-000007) ↗
FY2024Dec 31, 2024848+7.2%Novartis Form 6-K (0001370368-25-000007) ↗
FY2023Dec 31, 2023791+16.7%Novartis Form 6-K (0001370368-24-000007) ↗
FY2022Dec 31, 2022678+11.9%Novartis Form 6-K (0001370368-23-000008) ↗
FY2021Dec 31, 2021606+6.5%Novartis Form 6-K (0001370368-22-000009) ↗
FY2020Dec 31, 2020569+18.3%Novartis Form 6-K (0001370368-21-000008) ↗
FY2019Dec 31, 2019481+5.3%Novartis Form 6-K (0001370368-20-000007) ↗
FY2018Dec 31, 2018457–Novartis Form 6-K (0001370368-19-000006) ↗

Breakdown

What makes up net Sales in the U.S.

Cite this data

StockData. (2026). Novartis Net Sales in the U.S. ($M), annual FY2018–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-tafinlar-mekinist-us-sales

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.